Tumour markers in prostate cancer III: Biomarkers in urine

By Roobol Monique J.   Haese Alexander   Bjartell Anders  

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 85-89

Informa Healthcare

Access to resources Recommend Favorite

Diagnostic markers and prognostic factors in thyroid cancer

By Vriens Menno R   Schreinemakers Jennifer MJ   Suh Insoo   Guerrero Marlon A   Clark Orlo H  

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1283-1293

Future Medicine

Access to resources Recommend Favorite

Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications

By Hahn Noah M   Kelley Mark R   Klaunig James E   Koch Michael O   Li Lang   Sweeney Christopher J  

Future Oncology, Vol. 3, Iss. 6, 2007-12 ,pp. : 665-682

Future Medicine

Access to resources Recommend Favorite

Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients

By Brechot J.M.   Chevret S.   Nataf J.   Le Gall C.   Fretault J.   Rochemaure J.   Chastang C.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 385-391

Elsevier

Access to resources Recommend Favorite

The Prognostic Value of Serum and Immunohistochemical Tumour Markers in Advanced Gastric Cancer

By Webb A.   Scott-Mackie P.   Cunningham D.   Norman A.   Andreyev J.   O'Brien M.   Bensted J.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 63-68

Elsevier

Access to resources Recommend Favorite